In this episode of the LiverHealthPOD John, Will and Paul discuss new developments in Hepatitis B.
Hepatitis B affects over 300 million people worldwide and remains the leading cause of liver cancer globally — yet for decades, treatment options have been limited to viral suppression rather than cure. In this episode we break down the exciting wave of new therapies that are changing what's possible for people living with chronic hepatitis B.
If you like the Podcast don't forget to like and subscribe and send us an email with your stories to LiverHealthPOD.
Podden och tillhörande omslagsbild på den här sidan tillhör
LiverHealthPOD. Innehållet i podden är skapat av LiverHealthPOD och inte av,
eller tillsammans med, Poddtoppen.